Abstract
The present work focused on antioxidant and enzyme inhibitory potential of different solvent extracts (ethyl acetate, methanol and water) from Artedia squamata. Cholinesterase, tyrosinase, α-amylase and α-glucosidase inhibitory activities of the extracts were tested by microtitre plate assays. Antioxidant abilities were tested using free radical scavenging (DPPH and ABTS), reducing power (FRAP and CUPRAC), total antioxidant capacity and ferric ion chelating assays. The total phenolic contents of these extracts ranged from 26.24 to 35.16 mg GAEs/g extract. Methanol and water extracts showed higher phenolic content, DPPH and ABTS scavenging activity and reducing power activities, while ethyl acetate extract had highest chelating and inhibition abilities on AChE, α-amylase and α- glucosidase. With regard to tyrosinase inhibitory activity, water extract showed a good inhibitory activity with 11.91 mg KAEs/g. Present study showed that Artedia squamata can be considered as good source of natural agents for food and drug applications.
Keywords: Artedia squamata, antioxidant, cholinesterase, diabetes, tyrosinase, Turkey.
Graphical Abstract
Current Bioactive Compounds
Title:Biological Activities of Three Extracts from Artedia squamata: A Study on Antioxidant and Enzyme Inhibitory Potential
Volume: 11 Issue: 3
Author(s): Gokhan Zengin, Ramazan Ceylan, Sengul Uysal and Abdurrahman Aktumsek
Affiliation:
Keywords: Artedia squamata, antioxidant, cholinesterase, diabetes, tyrosinase, Turkey.
Abstract: The present work focused on antioxidant and enzyme inhibitory potential of different solvent extracts (ethyl acetate, methanol and water) from Artedia squamata. Cholinesterase, tyrosinase, α-amylase and α-glucosidase inhibitory activities of the extracts were tested by microtitre plate assays. Antioxidant abilities were tested using free radical scavenging (DPPH and ABTS), reducing power (FRAP and CUPRAC), total antioxidant capacity and ferric ion chelating assays. The total phenolic contents of these extracts ranged from 26.24 to 35.16 mg GAEs/g extract. Methanol and water extracts showed higher phenolic content, DPPH and ABTS scavenging activity and reducing power activities, while ethyl acetate extract had highest chelating and inhibition abilities on AChE, α-amylase and α- glucosidase. With regard to tyrosinase inhibitory activity, water extract showed a good inhibitory activity with 11.91 mg KAEs/g. Present study showed that Artedia squamata can be considered as good source of natural agents for food and drug applications.
Export Options
About this article
Cite this article as:
Zengin Gokhan, Ceylan Ramazan, Uysal Sengul and Aktumsek Abdurrahman, Biological Activities of Three Extracts from Artedia squamata: A Study on Antioxidant and Enzyme Inhibitory Potential, Current Bioactive Compounds 2015; 11 (3) . https://dx.doi.org/10.2174/1573407211666151002002314
DOI https://dx.doi.org/10.2174/1573407211666151002002314 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Genes and Hypertension
Current Pharmaceutical Design Endothelial Dysfunction and Atherosclerosis: Focus on Novel Therapeutic Approaches
Recent Patents on Cardiovascular Drug Discovery Physiology and Therapeutic Potential of the Thymic Peptide Thymulin
Current Pharmaceutical Design Bioactive Molecules from the <i>Alpinia</i> Genus: A Comprehensive Review
Current Pharmaceutical Biotechnology Emerging Targeted Therapies in Metastatic Renal Cell Carcinoma
Current Clinical Pharmacology Safety and Efficacy of Aliskiren in the Treatment of Hypertension and Associated Clinical Conditions
Current Drug Safety Clinical Predictors of Diabetic Retinopathy Progression; A Systematic Review
Current Diabetes Reviews Bioactive Polyphenols from Grapes and Wine Emphasized with Resveratrol
Current Pharmaceutical Design Expanding the Therapeutic Potential of Statins by Means of Nanotechnology Enabled Drug Delivery Systems
Current Topics in Medicinal Chemistry National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness- Alzheimers Disease (CATIE-AD): Baseline Characteristics
Current Alzheimer Research Barriers to Risk Stratification Accuracy in Ischemic Heart Disease in Women: The Role of Non-Obstructive Coronary Artery Disease
Current Pharmaceutical Design Antihypertensive Therapy in Children: Differences in Medical Approach Between the United States and Europe
Current Medicinal Chemistry Pathophysiology of Atherosclerosis: The Role of Inflammation
Current Pharmaceutical Design Evaluation of Homocysteine, Vitamin B12 and Folic Acid Levels During all the Trimesters in Pregnant and Preeclamptic Womens
Current Hypertension Reviews Tear Film Osmolarity, Ocular Surface Disease and Glaucoma: A Review
Current Medicinal Chemistry Antagonism of Endothelin (ETA and ETB) Receptors During Renovascular Hypertension-Induced Vascular Dementia Improves Cognition
Current Neurovascular Research Invasive and Non-invasive Monitoring of Hepatitis C Virus-Induced Liver Fibrosis: Alternatives or Complements?
Current Pharmaceutical Biotechnology Clinical Approach for the Treatment of Obesity-associated Diseases
Current Pharmaceutical Design Novel Anticoagulants vs Warfarin for Stroke Prevention in Atrial Fibrillation
Cardiovascular & Hematological Disorders-Drug Targets Anticoagulant Prevention in Patients with Atrial Fibrillation: Alternatives to Vitamin K Antagonists
Current Pharmaceutical Design